Literature DB >> 4358536

Relationship of antigenicity of melanoma cells grown in 5-bromodeoxyuridine to reduced tumorigenicity.

S Silagi, E W Newcomb, M E Weksler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4358536

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  6 in total

1.  Use of epithelial cell cultures for studies on the mechanism of transformation by chemical carcinogens.

Authors:  I B Weinstein; N Yamaguchi; R Gebert; M E Kaighn
Journal:  In Vitro       Date:  1975 May-Jun

2.  Correlated suppression by 5-bromodeoxyuridine of tumorigenicity and plasminogen activator in mouse melanoma cells.

Authors:  J K Christman; S Silagi; E W Newcomb; S C Silverstein; G Acs
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

3.  Reversible suppression of malignancy and differentiation of melanoma cells.

Authors:  S Silagi
Journal:  Am J Pathol       Date:  1977-12       Impact factor: 4.307

4.  Loss of oncogenicity and concomitant increased immunogenicity of murine plasmacytoma cell lines.

Authors:  G D Sorenson; O S Pettengill; C C Cate
Journal:  Am J Pathol       Date:  1978-03       Impact factor: 4.307

5.  Histopathology and host response associated with reduced tumorigenicity of 5-bromodeoxyuridine--treated murine melanoma cells.

Authors:  K K Gyi; J R Wrathall
Journal:  Am J Pathol       Date:  1983-02       Impact factor: 4.307

6.  Leukocyte subpopulations elicited by a nontumorigenic variant of B16 melanoma: their role in direct rejection of the melanoma and in prevention of tumorigenesis in Winn assays.

Authors:  T A Calvelli; V H Freedman; S C Silverstein; S Silagi
Journal:  J Exp Med       Date:  1982-12-01       Impact factor: 14.307
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.